Related Experiment Video
Updated: Jul 20, 2026

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
ASPP2: a gene that controls life and death in vivo
Virginie Vives1, Elizabeth A Slee, Xin Lu
1Ludwig Institute for Cancer Research, University College London, 91 Riding House Street, London, UK.
Abstract:
The fundamental role of apoptosis in tumor prevention and the important role of p53 in this process are now universally recognized. Recently, several families of p53-binding proteins have been shown to influence p53's decision to direct the cells either into the apoptotic pathway or in cell cycle arrest. Among them, the ASPP family specifically regulate p53-dependent apoptosis. Its member ASPP2 was discovered more than 10 years ago as a binding partner of p53 and its role as a positive regulator of p53 mediated apoptosis has been clearly established in vitro. However, its physiological importance in vivo has just emerged through the generation and characterisation of the ASPP2-deficient mice. We now know that ASPP2 is a haploinsufficient tumor suppressor and an important activator of p53 during mouse development and tumor suppression in vivo. ASPP2 might be a novel target for future cancer therapy.
Insights
ASPP2 protein is crucial for triggering apoptosis and preventing tumors. Studies in mice reveal ASPP2 acts as a tumor suppressor, highlighting its potential as a cancer therapy target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Apoptosis is vital for tumor prevention, with p53 playing a key role.
- p53-binding proteins modulate p53's function in apoptosis and cell cycle arrest.
- The ASPP family specifically regulates p53-dependent apoptosis.
Purpose of the Study:
- To investigate the in vivo physiological importance of ASPP2.
- To characterize ASPP2-deficient mice to understand its role in development and tumor suppression.
Main Methods:
- Generation and characterization of ASPP2-deficient mice.
- In vitro studies on p53-binding proteins and apoptosis regulation.
Main Results:
- ASPP2 is a haploinsufficient tumor suppressor in vivo.
- ASPP2 is an important activator of p53 during mouse development.
- ASPP2 plays a critical role in tumor suppression in vivo.
Conclusions:
- ASPP2's role as a positive regulator of p53-mediated apoptosis is confirmed in vivo.
- ASPP2 functions as a haploinsufficient tumor suppressor, crucial for development and cancer prevention.
- ASPP2 represents a potential novel target for future cancer therapies.
More Related Videos
10:39A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
Published on: September 17, 2020
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Gene Regulation During Sporulation
RNA Splicing
Replicative Cell Senescence
Replicative Cell Senescence